Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

804
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
804
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

770
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
770
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

307
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
307

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical trials for continuously monitored and updated AI systems.

Nature medicine·2026
Same author

Is AI actually improving healthcare?

Nature medicine·2026
Same author

The Search for the Golden Egg: Applied Large Language Models to Detect Patients With Potential Exposure to Avian Influenza.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

DEPICT: Diffusion-Enabled Permutation Importance for Image Classification Tasks.

Computer vision - ECCV ... : ... European Conference on Computer Vision : proceedings. European Conference on Computer Vision·2025
Same author

Estimating the Population-Level Impact of Empiric Antianaerobic Antibiotics among U.S. Adults Hospitalized with Sepsis.

American journal of respiratory and critical care medicine·2024
Same author

Racial differences in laboratory testing as a potential mechanism for bias in AI: A matched cohort analysis in emergency department visits.

PLOS global public health·2024

Related Experiment Video

Updated: Jan 15, 2026

Author Spotlight: Exploring Breathing Techniques and Digital Solutions for Enhancing Running Performance
06:26

Author Spotlight: Exploring Breathing Techniques and Digital Solutions for Enhancing Running Performance

Published on: September 27, 2024

918

Optimizing Loop Diuretic Treatment for Mortality Reduction in Patients With Acute Dyspnea Using a Practical Offline

Jung Min Lee1, Shengpu Tang1,2, Michael Sjoding3

  • 1Division of Computer Science and Engineering, College of Engineering, University of Michigan, 2260 Hayward St, Ann Arbor, MI, 48109, United States, 1 7346474832.

JMIR Medical Informatics
|October 10, 2025
PubMed
Summary

A new pipeline for offline reinforcement learning (RL) improves clinical decision-making for loop diuretics. This approach significantly reduces in-hospital mortality by optimizing treatment policies compared to standard clinician behavior.

Keywords:
artificial intelligenceclinical decision supportdynamic treatment regimeloop diureticreinforcement learningtreatment recommendationtreatment selection

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.3K
Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury
07:17

Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury

Published on: March 22, 2024

1.6K

Related Experiment Videos

Last Updated: Jan 15, 2026

Author Spotlight: Exploring Breathing Techniques and Digital Solutions for Enhancing Running Performance
06:26

Author Spotlight: Exploring Breathing Techniques and Digital Solutions for Enhancing Running Performance

Published on: September 27, 2024

918
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.3K
Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury
07:17

Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury

Published on: March 22, 2024

1.6K

Area of Science:

  • Clinical informatics
  • Machine learning in healthcare
  • Reinforcement learning applications

Background:

  • Offline reinforcement learning (RL) is increasingly used for clinical decision-making.
  • Existing methods lack standardization, leading to overfitted policies and inaccurate evaluations.
  • A robust pipeline is needed to improve reliability and clinical workflow integration.

Purpose of the Study:

  • Introduce a practical pipeline, Pipeline for Learning Robust Policies in Reinforcement Learning (PROP-RL), for offline RL in clinical settings.
  • Enhance policy robustness and minimize disruption to clinical workflows.
  • Demonstrate efficacy in optimizing loop diuretic treatment for hospitalized patients.

Main Methods:

  • Modeled loop diuretic management as an offline RL problem using electronic health record data.
  • Defined a discrete state space, binary action space (diuretic use), and in-hospital mortality reward function.
  • Trained and evaluated the policy on a large cohort of adult inpatients, comparing against clinician behavior.

Main Results:

  • The study included 36,570 hospitalizations.
  • The learned policy aligned with clinicians in most states but diverged in 2 states.
  • In cases of divergence, the RL policy significantly reduced mortality from 3.8% to 2.2% (1.6% reduction, P=.006).

Conclusions:

  • The PROP-RL pipeline offers a robust approach for offline RL in sequential treatment selection.
  • Highlights the importance of state representation and policy evaluation in clinical RL.
  • Identifies potential improvements in current loop diuretic treatment strategies and provides a blueprint for future clinical RL applications.